The Small Molecule 2-Azido-2-deoxy-glucose Is a Metabolic Chemical Reporter of O-GlcNAc Modifications in Mammalian Cells, Revealing an Unexpected Promiscuity of O-GlcNAc Transferase.
Balyn W ZaroAnna R BattKelly N ChuhMarisol X NavarroMatthew R PrattPublished in: ACS chemical biology (2017)
Glycans can be directly labeled using unnatural monosaccharide analogs, termed metabolic chemical reporters (MCRs). These compounds enable the secondary visualization and identification of glycoproteins by taking advantage of bioorthogonal reactions. Most widely used MCRs have azides or alkynes at the 2-N-acetyl position but are not selective for one class of glycoprotein over others. To address this limitation, we are exploring additional MCRs that have bioorthogonal functionality at other positions. Here, we report the characterization of 2-azido-2-deoxy-glucose (2AzGlc). We find that 2AzGlc selectively labels intracellular O-GlcNAc modifications, which further supports a somewhat unexpected, structural flexibility in this pathway. In contrast to the endogenous modification N-acetyl-glucosamine (GlcNAc), we find that 2AzGlc is not dynamically removed from protein substrates and that treatment with higher concentrations of per-acetylated 2AzGlc is toxic to cells. Finally, we demonstrate that this toxicity is an inherent property of the small-molecule, as removal of the 6-acetyl-group renders the corresponding reporter nontoxic but still results in protein labeling.
Keyphrases
- small molecule
- protein protein
- induced apoptosis
- crispr cas
- blood glucose
- magnetic resonance
- oxidative stress
- cell cycle arrest
- type diabetes
- amino acid
- molecular docking
- blood pressure
- pet imaging
- combination therapy
- reactive oxygen species
- adipose tissue
- cell proliferation
- insulin resistance
- signaling pathway
- magnetic resonance imaging
- molecular dynamics simulations
- pi k akt
- smoking cessation
- glycemic control
- replacement therapy